Board Disclosures

The leadership of the Journal of Alzheimer's Disease has disclosed the following information in keeping with the journal's disclosure policy.

George Perry, PhD, Editor-in-Chief
Consultant/Advisory Boards: Alzheimer Research and Prevention Foundation, Nervgen, ACT-AD, Alzheimer Foundation of America, Synaptogenix
Equity Ownership/Stock Options: Neurotez, Neurotrope
Other: IOS Press (strategic advisor)

Paula Moreira, PhD, Co-Editor-in-Chief
Nothing to Disclose

Beth Kumar, Managing Editor
Nothing to Disclose

Jesus Avila, PhD, Deputy Editor
Nothing to Disclose

Daniela Galimberti, PhD, Deputy Editor
Nothing to Disclose

Xiongwei Zhu, PhD, Deputy Editor
Nothing to Disclose

Madeleine Hackney, PhD, Reviews Editor
Nothing to Disclose

Dharma Singh Khalsa, MD, Prevention Editor
Consultant/Advisory Boards: President/Medical Director of Alzheimer's Research and Prevention Foundation

Allyson Rosen, PhD, ABPP-CN, Ethics Editor
Nothing to Disclose

Aaron A. Sorensen, Scientometrics Editor
Equity Ownership/Stock Options: emocha Mobile Health, Inc.

Last updated 7 January 2024